NextPlat Corp (NASDAQ:NXPL) Short Interest Up 1,762.1% in December

NextPlat Corp (NASDAQ:NXPL) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 54,000 shares, a growth of 1,762.1% from the November 30th total of 2,900 shares. Based on an average trading volume of 119,400 shares, the short-interest ratio is presently 0.5 days. Approximately 0.4% of the shares of the company are short sold.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NextPlat stock. Omnia Family Wealth LLC bought a new position in shares of NextPlat Corp (NASDAQ:NXPL) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 93,429 shares of the company’s stock, valued at approximately $132,000. Omnia Family Wealth LLC owned 0.49% of NextPlat at the end of the most recent quarter. Hedge funds and other institutional investors own 1.30% of the company’s stock.

NextPlat Stock Performance

Shares of NextPlat stock traded down $0.03 during trading on Friday, reaching $1.15. The company’s stock had a trading volume of 124,780 shares, compared to its average volume of 277,401. NextPlat has a one year low of $0.71 and a one year high of $2.68. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.04 and a current ratio of 3.70. The firm has a market cap of $29.86 million, a price-to-earnings ratio of -1.69 and a beta of 0.85. The business’s fifty day moving average price is $1.03 and its 200-day moving average price is $1.13.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.